• FirefoxInstall the new Firefox »
  •  Dow Down 0.15% Nasdaq Down 0.21%

    Chimerix, Inc. (CMRX)

    -NasdaqGM
    39.97 Down 1.11(2.70%) 12:59PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:41.08
    Open:40.72
    Bid:40.10 x 100
    Ask:40.13 x 100
    1y Target Est:46.13
    Beta:1.017
    Earnings Date:Mar 5 - Mar 9 (Est.)
    Day's Range:39.52 - 40.90
    52wk Range:14.02 - 43.41
    Volume:320,585
    Avg Vol (3m):443,121
    Market Cap:1.46B
    P/E (ttm):N/A
    EPS (ttm):-1.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CMRXDown 2.70%1.46B
    GNBTUp 1.16%N/A
    GILDDown 1.21%154.29B
    SIGAUp 0.45%120.38M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):398.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.76
    Quarterly EPS Est (Dec-14) :-0.48
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel, oral antivirals to address unmet medical needs in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback